510(k) Report

510(k) · Cleared

Cleared

Cordis Trapease Permanent Vena Cava Filter with the Visease Angiographic Vessel Dilator; Models 466-P306AU & 466-P306BU

K020316510(k) TraditionalCleared Mar 20, 200249-day reviewClass II21 CFR 870.1200

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cordis Corp. · DQO Catheter, Intravascular, Diagnostic

Cleared on Mar 20, 2002 as substantially equivalent to K000062 (Cordis Corp., 2000) and 6 other predicates after a 49-day review. Its family tree reaches back 1 generation to 1991. 3 of the 14 devices in its family, counting itself, have a Class I recall. 6 later devices descend from it.

Decided
Mar 20, 2002
Review
49 days
Class
Class II
Product code
DQO
Recalls
None
Predicates
7

Its longest line of descent runs back 1 generation to K914007 (1991). 7 ancestors in all. 6 later devices descend from it, 1 citing it directly. 3 of the 14 devices in this family, counting this one, have a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2001: 2 other ancestors2000: 1 other ancestor1999: 1 other ancestor, 1 with a Class I recall11998: 2 other ancestors2004: 1 descendant cleared, 1 with a Class I recall12014: 1 descendant cleared2010: 1 descendant cleared, 1 with a Class I recall12017: 1 descendant cleared2018: 2 descendants clearedK914007 · Cordis 5.2 French Super Torque Plus Cardio Cath · Cordis Corp. · 19911990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 6 other ancestors, 1 with a Class I recall1 1 generation forward: 1 descendant, 1 with a Class I recall12 generations forward: 3 descendants, 1 with a Class I recall13 generations forward: 1 descendant4 generations forward: 1 descendant K914007 · Cordis 5.2 French Super Torque Plus Cardio Cath · Cordis Corp. · 19910
  1. Root · 1 generation backK914007 Cordis 5.2 French Super Torque Plus Cardio CathCordis Corp. · 1991
  2. This deviceK020316 Cordis Trapease Permanent Vena Cava Filter with the Visease…Cordis Corp. · 2002
  3. Descendant · cites it directly · 5 of its ownK034050 Cordis Optease Vena Cava Filter, Models 466-F220A and 466-F220B…Cordis Corporation · 2004 · Recalled (Class I)
  4. Descendant · 2 generations on · 2 of its ownK162875 Sentry IVC filterNovate Medical, Ltd. · 2017
  5. Descendant · 3 generations on · 1 of its ownK173236 Sentry IVC FilterNovate Medical, Ltd. · 2018
  6. Descendant · 2 generations on · 1 of its ownK091077 Optease Vena Cava Filter and Retrieval CatheterCordis Corp., A Johnson & Johnson Co. · 2010 · Recalled (Class I)
  7. Descendant · 4 generations on · 0 of its ownK181202 Sentry IVC FilterNovate Medical, Ltd. · 2018

Showing 5 of 6 descendants. See all descendants

Descendants cleared per year

2004: 12010: 12014: 12017: 12018: 2
2004high 2 (2018) · low 0 (2005)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 6 · See all
  • K034050Cordis Optease Vena Cava Filter, Models 466-F220A and 466-F220B; Retrievable Catheter…Cordis Corporation · 2004 · cites it directly5descendants
  • K162875Sentry IVC filterNovate Medical, Ltd. · 2017 · 2 generations on2descendants
  • K173236Sentry IVC FilterNovate Medical, Ltd. · 2018 · 3 generations on1descendant
  • K091077Optease Vena Cava Filter and Retrieval CatheterCordis Corp., A Johnson & Johnson Co. · 2010 · 2 generations on1descendant
  • K181202Sentry IVC FilterNovate Medical, Ltd. · 2018 · 4 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K914007Cordis 5.2 French Super Torque Plus Cardio CathCordis Corp.1991—
0 (this device)K020316Cordis Trapease Permanent Vena Cava Filter with the Visease Angiographic…Cordis Corp.2002—
+1K034050Cordis Optease Vena Cava Filter, Models 466-F220A and 466-F220B; Retrievable…Cordis Corporation2004Class I
+2K162875Sentry IVC filterNovate Medical, Ltd.2017—
+3K173236Sentry IVC FilterNovate Medical, Ltd.2018—
+2K091077Optease Vena Cava Filter and Retrieval CatheterCordis Corp., A Johnson & Johnson Co.2010Class I
+4K181202Sentry IVC FilterNovate Medical, Ltd.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199820
199911
200010
200120

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200411
201011
201410
201710
201820
FIG. 1 — Lineage of K020316, 1991–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

3 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQO device

  1. #1 K254278 Arterial Pressure Monitoring Set/Trayscore 14.4 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (7)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K000062Cordis Trapease Permanent Vena Cava Filter and Introduction Kit
Summary page 4
…ena Cava Filter with the VisEase Angiographic Vessel Dilator is substantially equivalent to: e Cordis TrapEase Permanent Vena Cava Filter and Introduction Kit (510(k) #K000062, #K003964 and #K010083) e Cordis 5F Super Torque MB Angiographic Catheter (510(k) #K992347). e Cordis 52 F Super Torque Plus An…
Cordis Corp.2000—
*K003964Trapease Permanent Vena Filter and Introduction Kit, Models 466-P306A and 466-P306B
Summary page 4
…ilter with the VisEase Angiographic Vessel Dilator is substantially equivalent to: e Cordis TrapEase Permanent Vena Cava Filter and Introduction Kit (510(k) #K000062, #K003964 and #K010083) e Cordis 5F Super Torque MB Angiographic Catheter (510(k) #K992347). e Cordis 52 F Super Torque Plus Angiographic…
Cordis Corp.2001—
*K010083Trapease Permanent Vena Cava Filter and Introduction Kit, Model 466-P306A
Summary page 4
…e VisEase Angiographic Vessel Dilator is substantially equivalent to: e Cordis TrapEase Permanent Vena Cava Filter and Introduction Kit (510(k) #K000062, #K003964 and #K010083) e Cordis 5F Super Torque MB Angiographic Catheter (510(k) #K992347). e Cordis 52 F Super Torque Plus Angiographic Catheter (51…
Cordis Corp.2001—
*K992347Cordis Super Torque MB Angiographic Catheter with Radiopaque Marker Bands
Summary page 4
…: e Cordis TrapEase Permanent Vena Cava Filter and Introduction Kit (510(k) #K000062, #K003964 and #K010083) e Cordis 5F Super Torque MB Angiographic Catheter (510(k) #K992347). e Cordis 52 F Super Torque Plus Angiographic Catheter (510(k) #K914007) e Cordis Brite Tip Catheter Sheath Introducer & Vesse…
Cordis Corp.1999Class I
*K914007Cordis 5.2 French Super Torque Plus Cardio Cath
Summary page 4
…k) #K000062, #K003964 and #K010083) e Cordis 5F Super Torque MB Angiographic Catheter (510(k) #K992347). e Cordis 52 F Super Torque Plus Angiographic Catheter (510(k) #K914007) e Cordis Brite Tip Catheter Sheath Introducer & Vessel Dilator (510(k) #K983023 and #K984500) TRAPEASE™ Permane…
Cordis Corp.1991—
*K983023Modification to Cordis Brite Tip Catheter Sheath Introducer System
Summary page 4
…eter (510(k) #K992347). e Cordis 52 F Super Torque Plus Angiographic Catheter (510(k) #K914007) e Cordis Brite Tip Catheter Sheath Introducer & Vessel Dilator (510(k) #K983023 and #K984500) TRAPEASE™ Permanent Vena Cava Filter with the VISEASE™ Angiographic Vesse! Dilator Cordis Corporati…
Cordis Corp.1998—
*K984500Cordis Brite Tip Catheter Sheath Introducer System
Summary page 4
…#K992347). e Cordis 52 F Super Torque Plus Angiographic Catheter (510(k) #K914007) e Cordis Brite Tip Catheter Sheath Introducer & Vessel Dilator (510(k) #K983023 and #K984500) TRAPEASE™ Permanent Vena Cava Filter with the VISEASE™ Angiographic Vesse! Dilator Cordis Corporation, a Johnson…
Cordis Corp.19981

Also cleared against K000062: 2 other devices →

What descends from it? (6)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K034050Cordis Optease Vena Cava Filter, Models 466-F220A and 466-F220B; Retrievable Catheter… Class ICordis Corporation20045

Has anything in its family been recalled? (3 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K992347Cordis Super Torque MB Angiographic Catheter with Radiopaque Marker BandsCordis Corp. · 1999 · Direct predicate · ◆ in the 1999 ancestors bar of FIG. 15 Class I recalls
  • K034050Cordis Optease Vena Cava Filter, Models 466-F220A and 466-F220B; Retrievable Catheter, Model 466-C220FCordis Corporation · 2004 · Cites it directly · ◆ in the 2004 descendants bar of FIG. 11 Class I recall
  • K091077Optease Vena Cava Filter and Retrieval CatheterCordis Corp., A Johnson & Johnson Co. · 2010 · 2 generations on · ◆ in the 2010 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • 2 of the 7 ancestors have a recall of any class; 1 has a Class I recall.
  • Of its descendants, K034050 (Cordis Corporation, 2004) has gone furthest, with 5 descendants of its own.
  • 2 other devices also cite its predicate K000062.

How does its category compare?

All DQO devices

DQO Catheter, Intravascular, Diagnostic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DQO

2in 2025

2007: 82008: 32009: 82010: 72011: 62012: 152013: 22014: 32015: 102016: 42017: 102018: 102019: 62020: 32021: 12022: 42023: 42024: 42025: 22026 (partial year): 3
2007high 15 (2012) · low 1 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQO

148in 2024

2007: 106 days median2008: 80 days median2009: 58 days median2010: 137 days median2011: 74 days median2012: 94 days median2014: 109 days median2015: 209 days median2016: 89 days median2017: 176 days median2018: 234 days median2019: 113 days median2020: 30 days median2022: 181 days median2023: 73 days median2024: 148 days median2026 (partial year): 85 days median
2007high 234 (2018) · low 30 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQO

1in 2023

2007: 142008: 42009: 72010: 112011: 72012: 22013: 12015: 1, 1 Class I2016: 2, 1 Class I2017: 12018: 22019: 712020: 4, 4 Class I2022: 12023: 1, 1 Class I2026 (partial year): 24, 4 Class I
2007high 71 (2019) · low 0 (2014)2026

Class I (11 since 2007) Class II/III not classified

Adverse event reports per year · DQO

656in 2025

2007: 5642008: 7262009: 9332010: 5562011: 6252012: 5322013: 7532014: 6012015: 6282016: 6142017: 8732018: 7772019: 3862020: 3122021: 3382022: 3792023: 3912024: 5112025: 656
2007high 933 (2009) · low 312 (2020)2025

MAUDE reports naming product code DQO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007810614564
20083804726
20098587933
2010713711556
20116747625
201215942532
20132—1753
201431090601
2015102091 (1)628
20164892 (1)614
2017101761873
2018102342777
2019611371386
20203304 (4)312
20211—0338
202241811379
20234731 (1)391
202441480511
20252—0656
202638524 (4)—

What is it indicated for?

The Cordis TrapEase™ Permanent Vena Cava Filter is indicated for the prevention of recurrent pulmonary embolism via percutaneous placement in the inferior vena cava in the following situations: pulmonary thromboembolism when anticoagulants are contraindicated, failure of anticoagulant therapy in thromboembolic diseases, emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced and chronic…

Read the full statement (98 words)

The Cordis TrapEase™ Permanent Vena Cava Filter is indicated for the prevention of recurrent pulmonary embolism via percutaneous placement in the inferior vena cava in the following situations: pulmonary thromboembolism when anticoagulants are contraindicated, failure of anticoagulant therapy in thromboembolic diseases, emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced and chronic, recurrent pulmonary embolism where anticoagulant therapy has failed or is contraindicated.

The VisEase Angiographic Vessel Dilator is designed to provide angiographic visualization and linear measurement of the vasculature when combined with the delivery of radiopaque contrast media to the vena cava.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K020316: Cordis Trapease Permanent Vena Cava Filter with the Visease Angiographic Vessel Dilator; Models 466-P306AU & 466-P306BU.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K020316

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026